Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-016-3098-3
Published Online: 2016-07-05
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chow, Laura Q. M.
Smith, David C.
Tan, Antoinette R.
Denlinger, Crystal S.
Wang, Ding
Shepard, Dale R.
Chaudhary, Archana
Lin, Yong
Gao, Ling
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2016-07-05